Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer

Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer

Aim:Around 40% of non-small cell lung cancers have stage 3b or 4 disease at the time of diagnosis. In the treatment, platinum-based therapy can still be used in patients who do not carry a driver mutation or who are not suitable for immunotherapy with advanced non-small cell lung cancers (NSCLC). Th...

Full description

Bibliographic Details
Main Authors: Serdar ATA, Ahmet Ziya BAYHAN, Oğuzhan KESEN, Burcu ARSLAN BENLİ, Tolga KÖŞECİ, Hakan DEMİR, Timuçin ÇİL, Berna BOZKURT DUMAN
Format: Article
Language:English
Published: Galenos Yayincilik 2023-09-01
Series:Namık Kemal Tıp Dergisi
Subjects:
non-small cell lung cancer
carboplatin-paclitaxel
triweekly
progression free survival
overall survival
Online Access: http://namikkemalmedj.com/archives/archive-detail/article-preview/efficacy-comparison-between-weekly-and-triweekly-r/62095

Internet

http://namikkemalmedj.com/archives/archive-detail/article-preview/efficacy-comparison-between-weekly-and-triweekly-r/62095

Similar Items